Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years--United States, October 12-January 1, 2023

Authors :: Hause, Anne M.
Marquez, Paige
Zhang, Bicheng
Su, John R.
Myers, Tanya R.
Gee, Julianne
Panchanathan, Sarada S.
Thompson, Deborah
Shimabukuro, Tom T.
Shay, David K.
Source :: Morbidity and Mortality Weekly Report. January 13, 2023, Vol. 72 Issue 2, p39, 5 p.
Publication Year :: 2023
Abstract: On October 12, 2022, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for bivalent (mRNA encoding the spike protein from the SARS-CoV-2 ancestral strain and BA.4/BA.5 Omicron [...]

Subjects :: United States. Food and Drug Administration -- Safety and security measures
Pfizer Inc. -- Safety and security measures
Vaccination -- Health aspects -- Safety and security measures
Messenger RNA -- Safety and security measures -- Health aspects
Vaccines -- Safety and security measures -- Health aspects
Pharmaceutical industry -- Safety and security measures -- Health aspects
Health

Tools